Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 367,012 | 342,488 | 263,180 | 316,827 | 228,713 |
| Marketable Securities | 19,832 | 72,715 | 174,809 | 198,563 | 67,546 |
| Receivables | 150,540 | 131,227 | 119,711 | 112,130 | 106,843 |
| Inventories | 26,748 | 24,156 | 24,277 | 23,395 | 29,526 |
| Other current assets | 11,722 | 8,239 | 8,077 | 18,239 | 4,555 |
| TOTAL | $596,019 | $596,812 | $605,291 | $681,508 | $448,730 |
| Non-Current Assets | |||||
| PPE Net | 94,103 | 92,012 | 102,499 | 109,465 | 85,873 |
| Investments And Advances | 0 | 0 | 0 | 0 | 29,555 |
| Intangibles | 862,447 | 895,894 | 931,026 | 969,440 | 331,736 |
| Other Non-Current Assets | 85,469 | 96,511 | 101,218 | 109,365 | 92,437 |
| TOTAL | $1,042,019 | $1,084,417 | $1,134,743 | $1,188,270 | $539,601 |
| Total Assets | $1,638,038 | $1,681,229 | $1,740,034 | $1,869,778 | $988,331 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 200,777 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 21,607 | 20,334 | 20,510 | 17,921 | 24,965 |
| Accrued Expenses | 75,067 | 68,230 | 55,211 | 56,100 | 36,381 |
| Other current liabilities | 409 | 2,130 | 7,557 | 5,192 | 4,029 |
| TOTAL | $301,241 | $96,304 | $89,932 | $87,232 | $73,183 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 412,948 | 619,103 | 617,329 | 618,794 | 214,472 |
| TOTAL | $434,458 | $643,388 | $652,079 | $674,269 | $220,854 |
| Total Liabilities | $735,699 | $739,692 | $742,011 | $761,501 | $294,037 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 128,461 | 127,610 | 127,458 | 124,026 | 116,940 |
| Common Shares | 128 | 127 | 127 | 124 | 112 |
| Retained earnings | -325,781 | -247,055 | -159,087 | -14,837 | -7,185 |
| Other shareholders' equity | -206 | -1,674 | -3,899 | -638 | 10 |
| TOTAL | $902,339 | $941,537 | $998,023 | $1,108,277 | $694,294 |
| Total Liabilities And Equity | $1,638,038 | $1,681,229 | $1,740,034 | $1,869,778 | $988,331 |